BVS
BioventusANasdaq / Health Care Equipment & Services
Last Price
At close
2026-07-18
Current thesis
Q1 showed growth across all three businesses, stronger adjusted EBITDA, and a sharp improvement in operating cash flow. Sustained execution could support the bull scenario.
Posture
Constructive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta +0.1.
What can break
A valuation premium relative to the broader medical-equipment industry increases downside if growth or cash-flow expectations soften.
Momentum
87
Value
65
Sentiment
58
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $13.50 · Bull $16.00 · Bear $9.00
Data freshness
Prices
As of 2026-07-18
Fundamentals
As of 2026-07-17 • Vendor: Data Vendor v1
Scores
As of 2026-07-18 • Model: HYBRID_IC_RP
AI Memo
As of 2026-07-15 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-07-18
Investment thesis
As of 2026-07-18
Supporting evidence
What
Grade A · Constructive
Confidence Medium · Net Neutral
Target $14.80
Why
Momentum87 · Δ7d +0.3
Value65 · Δ7d +0.1
Sentiment58 · Δ7d +16.6
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Value · See fundamentals
Momentum
87
26% active weight
Current posture
7d trendFlat
Δ7d
+0.3
Δ21d
+60.6
Value
65
39% active weight
Current posture
7d trendFlat
Δ7d
+0.1
Δ21d
-2.2
Sentiment
58
34% active weight
Current posture
7d trendImproving
Δ7d
+16.6
Δ21d
-0.8
Why this grade
Composite grade A. Momentum 86.8 / Value 64.7 / Sentiment 58.1
Fundamentals (TTM)As of 2026-07-17
Fundamentals (TTM)
As of 2026-07-17
Market Cap
$1.01B
Beta
0.79
Shares Out
67.75M
P/E (TTM)
67.4
P/S (TTM)
1.11
P/FCF (TTM)
11.72
Rev YoY
+6.6%
EPS YoY
-211.3%
Gross Margin
+67.8%
Op Margin
+7.5%
Net Debt
$260.11M
Current Ratio
1.69
As of 2026-07-18 • Updated nightlySource: Internal modelMethodology